Evidence map›Paper›PMID 33374116›Full record

ArticleNutrients2020

Basolateral Secretion from Caco-2 Cells Pretreated with Fecal Waters from Breast Cancer Patients Affects MCF7 Cell Viability.

Christine Bobin-Dubigeon, Jean-Marie Bard, Trang-Huyen Luu, Françoise Le Vacon, Hassan Nazih

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Specific microbiome patterns and their association with breast cancer: the intestinal microbiota as a potential biomarker and therapeutic strategy.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Christine Bobin-DubigeonEA 2160-IUML FR3473 CNRS, Université de Nantes, 44035 Nantes, France.ORCID 0000-0001-8944-3219
Jean-Marie BardEA 2160-IUML FR3473 CNRS, Université de Nantes, 44035 Nantes, France.ORCID 0000-0002-9123-8123
Trang-Huyen LuuEA 2160-IUML FR3473 CNRS, Université de Nantes, 44035 Nantes, France.
Françoise Le VaconBiofortis, Mérieux Nutrisciences, 44800 Saint-Herblain, France.
Hassan NazihEA 2160-IUML FR3473 CNRS, Université de Nantes, 44035 Nantes, France.ORCID 0000-0002-3607-295X
Centre National de la Recherche Scientifique · FR

Funding

Institut de Cancérologie de l'Ouest AO2016Ligue contre le cancer Comité 16
6 · The paper itself

Abstract

We hypothesized that the role of microbiota in breast cancer relates to its influence on gut lipid metabolism. This was tested in an in vitro model combining MCF-7 and Caco-2 cells. A total of 32 women newly diagnosed for breast cancer before any treatment and 28 healthy women provided their stools. Bacterial DNA was amplified by qPCR targeting 16s rRNA specific to Bacteroidetes and Firmicutes phyla,

Indexed as

BacteriaBreast NeoplasmsCaco-2 CellsCell SurvivalDNA, BacterialEnterocytesFatty Acids, VolatileFecesFemaleGastrointestinal MicrobiomeGene ExpressionHumansLipid MetabolismMCF-7 CellsMiddle AgedDNA, BacterialFatty Acids, Volatilebreast cancergutlipid metabolismmicrobiota

Identifiers

PMID33374116
PMCPMC7824055
OpenAlexW3117652905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.